RE:RE:RE:New Presentation Deck out for us April fools. If those business milestones are indeed achieved in the next two months as indicated we dont have long to wait and see what howie means by all these generalities. As an aside, unlike HydroQ, I have not see any data supporting that the .4% formulation is prescription, which is a good thing. No Phase 1-3 trials and FDA approval of the indications will be required if it remains a consumer cosmetic. If the Big Pharma partner takes it global, then there is the ticket to Japan. Rodan + Fields is non exclusive, so other partners promote 1067 wherever they like through whatever channels they desire.